Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Etanercept, a psoriasis treatment, caused hair loss in a patient.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

Anti-TNF therapy can cause a unique type of hair loss that may get better with topical treatments without stopping the therapy.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

New treatments for skin conditions in children include a preferred drug for birthmark reduction, proactive creams for eczema and vitiligo, a safe psoriasis medication, and special tissues and socks for eczema and fungal infections.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Skin changes during pregnancy are common, and non-invasive imaging is safe for monitoring these changes.

Anti-TNF therapy can cause hair loss and skin issues.

Switching from adalimumab to ixekizumab improved a patient's psoriasis and reversed hair whitening.

Some drugs used to treat immune conditions may cause different types of hair loss.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

Different types of cell death affect skin health and inflammation, and understanding them could improve treatments for skin diseases.

A patient lost all their hair while on rheumatoid arthritis medication.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Scalp psoriasis can cause different types of hair loss, with some patients developing permanent hair loss, and treatment may be stopped due to skin reactions.

New treatments for a chronic skin condition show promise, but individualized plans are crucial due to varying responses.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

Understanding drug interactions, side effects, and patient-specific factors is crucial for effective dermatological care.

Diagnosing alopecia areata is challenging and requires careful examination and various tests to distinguish it from other hair loss types.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Some drugs used to treat inflammation may cause hair loss.

Shrinking of oil glands in the skin is a key sign of hair loss linked to TNF inhibitor drugs and may improve if the treatment is stopped.

The Polish Dermatological Society recommends personalized treatment for cutaneous lupus, including lifestyle changes, medications, and monitoring, with specific drugs for severe cases.

Certain liver diseases respond well to specific treatments and have varying risks for liver cancer.

More research is needed to find the best treatment for dissecting cellulitis of the scalp.

Some skin conditions may increase the risk of heart disease, but are not yet included in cardiovascular prevention guidelines.

Colchicine might help treat different skin diseases, but more research is needed to confirm its effectiveness and safe dosage.

Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.

TNF-alpha inhibitors can cause various immune-related skin issues.